Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

ConclusionsOur study confirms that pembrolizumab is effective in the advanced UC real-world context, showing outcome differences between patients recurred or progressed after platinum-based chemotherapy.

http://link.springer.com/10.1007/s00262-024-03682-w

Source: Cancer Immunology, Immunotherapy - April 18, 2024 Category: Cancer & Oncology Source Type: research